Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion type Assertion NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_head.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion description "[We found that RSUME is expressed in human VHL tumors (renal clear-cell carcinoma (RCC), pheochromocytoma and hemangioblastoma) and by overexpressing or silencing RSUME in a pVHL-HIF-oxygen-dependent degradation stability reporter assay, we determined that RSUME is necessary for the loss of function of type 2 pVHL mutants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_provenance.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion evidence source_evidence_literature NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_provenance.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion SIO_000772 25500545 NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_provenance.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion wasDerivedFrom befree-2016 NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_provenance.
- NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_assertion wasGeneratedBy ECO_0000203 NP1247373.RAH62I5B2XdbWg2xkVHfJQ615zet01-IRprb9WuMqn-t0130_provenance.